Vitiligo, From Physiopathology to Emerging Treatments: A Review
Open accessThe DOI matches its Crossref record; 4 of the 4 references it cites were found in a registry or an index.
Abstract
Vitiligo is a chronic inflammatory skin disease leading to the loss of epidermal melanocytes. To date, treatment options for vitiligo patients are limited, lack sustained efficacy, and are mainly based on off-label use of immunosuppressive agents, such as systemic or topical steroids or topical calcineurin inhibitors, in association with the use of ultraviolet light. However, recent insights into the understanding of the immune pathogenesis of the disease have led to the identification of several therapeutic targets and the development of targeted therapies that are now being tested in clinical trials. In this review, based on the physiopathology of the disease, we summarize emerging targets that could be developed for the treatment of vitiligo and discuss recent and ongoing developments of drugs for the management of the disease.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Multifaceted pathways protect human skin from UV radiation
Natarajan, V. T., Ganju, P., Ramkumar, A., Grover, R., & Gokhale, R. S. (2014) · Nature Chemical Biology · doi:10.1038/nchembio.1548 · Cited by 244
T cells and the skin: from protective immunity to inflammatory skin disorders
Ho, A. W., & Kupper, T. S. (2019) · Nature Reviews Immunology · doi:10.1038/s41577-019-0162-3 · Cited by 241
Perspectives of New Advances in the Pathogenesis of Vitiligo: From Oxidative Stress to Autoimmunity
Wang, Y., Li, S., & Li, C. (2019) · Medical Science Monitor · doi:10.12659/msm.914898 · Cited by 176
Local heroes or villains: tissue-resident memory T cells in human health and disease
Sasson, S. C., Gordon, C. L., Christo, S. N., Klenerman, P., & Mackay, L. K. (2020) · Cellular & Molecular Immunology · doi:10.1038/s41423-019-0359-1 · Cited by 111
Cited by
Janus Kinase Inhibitors in the Treatment of Vitiligo: A Review
Qi, F., Liu, F., & Gao, L. (2021) · Frontiers in Immunology · doi:10.3389/fimmu.2021.790125 · Cited by 203
Epidemiology of vitiligo – a dual population-based approach
Mohr, N., Petersen, J., Kirsten, N., & Augustin, M. (2021) · Clinical Epidemiology · doi:10.2147/clep.s304155 · Cited by 41
Treatment Advances in Vitiligo: An Updated Review
Binti Ismail, I., Jabeen Bhat, Y., & Shurjeel ul Islam, M. (2025) · Dermatology Practical & Conceptual · doi:10.5826/dpc.1501a4600 · Cited by 15
“Since there is a significant role of CD8+ T lymphocytes in the production of vitiligo, it may be worthwhile to investigate and test therapeutics that block the CXCL9 and CXCL10 chemokines and their receptor, CXCR3, involved in the IFN-γ signaling pathway [69].”
Metadata
- Authors
- Migayron, L., Boniface, K., & Seneschal, J.
- Venue
- Dermatology and Therapy
- Published
- 2020-09-19
- Volume
- 10
- Issue
- 6
- Pages
- 1185-1198
- ISSN
- 2190-9172 (ISSN-L)
- 2193-8210
- OpenAlex
- W3087677305
- Cited by
- 82
- References
- 4
- FWCI
- 3.72
- Type
- journal article
- Language
- en
- Open access
- gold
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Vitiligo, From Physiopathology to Emerging Treatments: A Review. https://app.cochat.ai/papers/10.1007/s13555-020-00447-y
- The paper
- Migayron, L., Boniface, K., & Seneschal, J. (2020). Vitiligo, From Physiopathology to Emerging Treatments: A Review. Dermatology and Therapy. https://doi.org/10.1007/s13555-020-00447-y
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.